Sign in

NCT05047237Completed

Electronic Frailty Index (eFI)Cacious-Diabetes Care

eFIcacious-Diabetes Care: a Pilot Study of a Pharmacist-Led Optimization Intervention to Achieve Guideline-based Care for Frail Older Adults

Source: ClinicalTrials.gov · Last updated 2 Jul 2025

Brief summary (registry, in English)

The purpose of this research is to explore whether a pharmacist-led diabetes management program can help optimize diabetes care for older adults. Participation in this study will involve meeting with a pharmacist who works with subjects' doctors, getting some routine bloodwork typical for people with diabetes, and potentially adjusting the subject's diabetes medications to reach American Diabetes Association guidelines. This study aims to bring older adults with diabetes whose measurements and medications are different from the guidelines of the American Diabetes Association into guidelines-based ranges.

Status (registry)
Completed
Study type
Interventional
Enrollment
42 (actual)
First submitted
7 Sept 2021
Start date
29 Oct 2021
Primary completion date
1 Nov 2024
Lead sponsor
Wake Forest University Health Sciences
NCT number
NCT05047237

What you commit to

  • Study type: Interventional
  • Participants enrolled: 42
  • From 29 Oct 2021 to the primary completion date, 1 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosed Alzheimer's disease or related dementia (unable to participate)

Other

  • Moderate to severe hearing loss (due to phone interventions)
  • Non-English speaking (not all pharmacists speak a second language; subtleties may not be conveyed effectively)
  • No phone number available for patient (follow up contacts will be by telehealth or phone

Who the study is looking for

  • Attributed to a Atrium Health Wake Forest Baptist-affiliated Accountable Care Organization
  • At least 2 consecutive International Classification of Diseases 10th Revision (ICD-10) codes for type two diabetes mellitus in the prior 2 years
  • Has a calculable Electronic Frailty Index (eFI) score \>0.21
  • A glycosylated hemoglobin (HbA1c) value \<7.5% in the prior 2 years
  • Currently taking a sulfonylurea or insulin for Type 2 Diabetes Mellitus (T2DM)

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Atrium Health Wake Forest Baptist Health
Coordinator of this site? Confirm its status
Winston-SalemUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.